LOGIN
AAOS2018: Additional liposomal bupivacaine infiltration to ISBPB of no benefit in TSA
March 2018
AAOS2018: Additional liposomal bupivacaine infiltration to ISBPB of no benefit in TSA
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Interscalene Brachial Plexus Blockade with and without Liposomal-Released Bupivacaine Soft Tissue Infiltration in Shoulder Arthroplasty: A Randomized Controlled Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
75 patients scheduled for total shoulder arthroplasty under an interscalene brachial plexus block were randomized to either receive or not receive additional intraoperative infiltration of liposomal bupivacaine within the periarticular soft tissues. Patients were assessed for narcotic consumption over the first 24 hours after surgery, and pain scores over the first 72 hours postoperatively. Result...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.